COVID-19 in a severely immunosuppressed patient with life-threatening eosinophilic granulomatosis with polyangiitis
Abstract: Immunosuppressive therapies increase the susceptibility of patients to infections. The current pandemic with severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) compels clinicians to develop recommendations for successful clinical management and surveillance of immunocompromised patients at high risk for severe disease progression. With only few case studies published on SARS-CoV-2 infection in patients with rheumatic diseases, we report a 25-year-old male who developed moderate coronavirus disease 2019 (COVID-19) with fever, mild dyspnea, and no major complications despite having received high-dose prednisolone, cyclophosphamide, and rituximab for the treatment of highly active, life-threatening eosinophilic granulomatosis with polyangiitis (EGPA)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Frontiers in immunology. - 11 (2020) , 2086, ISSN: 1664-3224
- Keyword
-
COVID-19
SARS-CoV-2
Vaskulitis
EGPA
Immunsuppression
Rituximab
Cyclophosphamid
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2020
- Creator
- DOI
-
10.3389/fimmu.2020.02086
- URN
-
urn:nbn:de:bsz:25-freidok-1675147
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:47 PM CET
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schramm, Markus A.
- Venhoff, Nils
- Wagner, Dirk
- Thiel, Jens
- Huzly, Daniela
- Craig-Müller, Nils
- Panning, Marcus
- Hengel, Hartmut
- Kern, Winfried V.
- Voll, Reinhard
- Universität
Time of origin
- 2020